Jason Rando | Tiberend Strategic Advisors |
David Arthur | CEO, President & Director |
Mark Rosenblum | EVP, Finance & CFO |
Nadeem Mirza | SVP, Clinical Development |
Daniela Santiesteban | Director, Research and Business Development |
Wangzhi Li | Ladenburg Thalmann & Co. |
Aydin Huseynov | The Benchmark Company |
Hunter Diamond | Diamond Equity Research |
Ladies and gentlemen, thank you for standing by, and welcome to Salarius Pharmaceuticals Q4 and Year-end 2020 Financial Results Call. [Operator Instructions]. I would now like to hand the conference over to your host, Jason Rando with Tiberend Strategic Advisors. Sir, please go ahead.
Good afternoon, everyone, and thank you for joining Salarius Pharmaceuticals 2020 Fourth Quarter and Full Year Financial and Corporate Results Call.